SCHEMBL4151606

SCHEMBL4151606

C=Cc1ccc(C=Cc2ccc(N(C)CCO)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.43
APP P05067 8/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
CYBB P04839 2/20 0.39
NOX4 Q9NPH5 2/20 0.39
RELA Q04206 1/20 0.39
PTGS1 P23219 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
KLF5 Q13887 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 2/20 0.37
CASP1 P29466 2/20 0.37
HBB P68871 2/20 0.37
ALOX15 P16050 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B3 P37058 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2604882 0.84 RELA (0.58) NOX1APPL3MBTL1CYBBNOX4
SCHEMBL2604929 0.81 NPC1 (0.61) NOX1APPL3MBTL1CYBBNOX4
SCHEMBL14328196 0.81 NOX1 (0.42) NOX1APPL3MBTL1CYBBNOX4
SCHEMBL14329681 0.79 NOX1 (0.43) NOX1APPL3MBTL1CYBBNOX4
SCHEMBL13840827 0.79 NOX1 (0.46) NOX1APPL3MBTL1CYBBNOX4
Iodide SCHEMBL7032875 0.79 MEN1 (0.63) NOX1APPMEN1KMT2ANPC1
SCHEMBL4142559 0.79 MEN1 (0.46) NOX1APPL3MBTL1CYBBNOX4
Iodide SCHEMBL7032870 0.79 MEN1 (0.63) NOX1APPMEN1KMT2ANPC1
SCHEMBL12806229 0.78 ALDH1A1 (0.44) NOX1APPRELAKMT2AALDH1A1
SCHEMBL12733254 0.78 ALDH1A1 (0.44) KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090035576-A1 Nanoparticles for two-photon activated photodynamic therapy and imaging HEALTH RESEARCH, INC. 2009-02-05 US disclosed
US-20080233051-A1 Nanoparticles for two-photon activated photodynamic therapy and imaging HEALTH RESEARCH, INC. 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233051-A1 Nanoparticles for two-photon activated photodynamic therapy and imaging ORMDL3, PPOX, ORC3 NOX1 370/4885APP 1759/4885L3MBTL1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.